BioWorld Science

Oct. 24, 2011

View Archived Issues

Ibuprofen derivative mitigates effects of murine muscular dystrophy

Read More

New phosphodiesterase 3/4 inhibitor shows anti-inflammatory and bronchodilatory effects

Read More

Abbott reviews business highlights of third quarter 2011

Read More

Genfit's GFT-505 increases sensitivity to insulin in target organs

Read More

Cytonet expands SELICA III study to Canada

Read More

Study suggests montelukast improves pediatric atopic dermatitis

Read More

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Read More

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Read More

Korean research team presents novel angiogenesis inducers

Read More

New antisense oligonucleotides synthesized at Mirrx Therapeutics

Read More

Matrix Pharma claims novel thrombin inhibitors

Read More

Okayama University discloses new COX-1 inhibitors

Read More

Novel antivirals prepared at Vertex

Read More

Halozyme reports phase II data on ultrafast insulin analogue formulations

Read More

AMAG Pharmaceuticals terminates merger agreement

Read More

Dynavax and GSK add new target in Toll-like receptor inhibitor program

Read More

Intercell reports first-in-human data on Clostridium difficile vaccine

Read More

FDA to review linaclotide NDA

Read More

Daiichi Sankyo and AstraZeneca seek approval for new Nexium indication in Japan

Read More

CHMP clarifies opinion on pioglitazone and the risk of bladder cancer

Read More

Progenra and Tokyo Medical University begin rheumatoid arthritis collaboration

Read More

FDA issues update on drug interactions with linezolid

Read More

Silence Therapeutics and Mirna Therapeutics enter microRNA collaboration

Read More

First-in-human AVI-6003 trial advances

Read More

FDA approves label update for Prezista

Read More